Cargando…
Is the era of sorafenib over? A review of the literature
Hepatocellular carcinoma (HCC) is one of the most severe diseases worldwide. For the different stages of HCC, there are different clinical treatment strategies, such as surgical therapy for the early stage, and transarterial chemoembolization (TACE) and selective internal radiation therapy (SIRT) fo...
Autores principales: | Fan, Guanghan, Wei, Xuyong, Xu, Xiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7252361/ https://www.ncbi.nlm.nih.gov/pubmed/32518599 http://dx.doi.org/10.1177/1758835920927602 |
Ejemplares similares
-
Establishment and validation of a cholesterol metabolism-related prognostic signature for hepatocellular carcinoma
por: Tang, Linsong, et al.
Publicado: (2022) -
Efficacy of sequential therapies with sorafenib-sunitinib versus sunitinib-sorafenib in metastatic renal cell carcinoma: A systematic review and meta-analysis
por: Wen, Tingyu, et al.
Publicado: (2017) -
Successful treatment of paraganglioma with sorafenib: a case report and brief review of the literature
por: Lin, Yun, et al.
Publicado: (2013) -
Sorafenib-Induced Liver Failure: A Case Report and Review of the Literature
por: Van Hootegem, Anneleen, et al.
Publicado: (2011) -
Microvesicles: the functional mediators in sorafenib resistance
por: He, Cong, et al.
Publicado: (2022)